Silk Road Medical, Inc
NASDAQ: SILK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Charles S. McKhann
- Employees
- 474
- Headquarters
- Sunnyvale, United States
- IPO year
- 2019
- Market cap
- $1.1B
- Website
- https://silkroadmed.com
Loading SILK…
Loading profile data…Frequently asked questions about SILK
What does Silk Road Medical, Inc (SILK) do?
Silk Road Medical, Inc. operates as an American medical device company, focusing on innovative solutions for carotid artery disease. The firm's product portfolio is specifically engineered to support transcarotid artery revascularization (TCAR) procedures. Among its key offerings is the ENROUTE Transcarotid Neuroprotection System, designed to di...
Where does SILK trade?
Silk Road Medical, Inc (SILK) trades on the NASDAQ Global Select.
What sector is SILK in?
Silk Road Medical, Inc (SILK) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Silk Road Medical, Inc?
Charles S. McKhann is the chief executive officer of Silk Road Medical, Inc (SILK).
Where is Silk Road Medical, Inc headquartered?
Silk Road Medical, Inc is headquartered in United States.
Does SILK pay a dividend?
Silk Road Medical, Inc (SILK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SILK go public?
Silk Road Medical, Inc (SILK) completed its initial public offering in 2019.